Skip to main content

Prometic Life Sciences Inc (PLI-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 12.52
Day High 13.60
Open:12.95
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Top 1000
ProMetic Life Sciences is ranked 552 out of The Top 1000, Report on Business magazine’s exclusive ranking of Canada’s largest companies.
Description
Prometic Life Sciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its own orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Prometic Reports First Subject Dosed in Phase I Clinical Study with Single Ascending Doses of PBI-4547
- CNW Group - Mon Sep 9, 7:00AM CDT
CNW Group - CMTX
Mon Sep 9, 7:00AM CDT
Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in liver, respiratory, and kidney diseases, announced today that the first subject has been dosed in a Phase I clinical study of PBI-4547. PBI-4547 is a novel, orally active immune-metabolic agent which displays antidiabetic, antihyperlipidemic, anti-inflammatory and anti-fibrotic activity as shown in multiple animal models.
Prometic Life Sciences to Present at H.C. Wainwright & Co. 21st Annual Global Investment Conference
- PR Newswire - Wed Sep 4, 7:00AM CDT
PR Newswire - PRNW
Wed Sep 4, 7:00AM CDT
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Sept. 4, 2019 /CNW Telbec/ -  Prometic Life Sciences Inc.  (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, today announced that members of the management team will provide a business overview and update at the H.C. Wainwright & Co. 21st Annual Global Investment Conference at 11:15 EDT on Tuesday, September 10, 2019 in New York, USA .
Prometic Life Sciences to Present at H.C. Wainwright & Co. 21st Annual Global Investment Conference
- CNW Group - Wed Sep 4, 7:00AM CDT
CNW Group - CMTX
Wed Sep 4, 7:00AM CDT
Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, today announced that members of the management team will provide a business overview and update at the H.C. Wainwright & Co. 21st Annual Global Investment Conference at 11:15 EDT on Tuesday, September 10, 2019 in New York, USA.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 10.70 +25.23% increase
on 08/21/19
Period Open:12.17
Price movement based on the high, low and last over the given period.
17.00 -21.18% decrease
on 09/13/19
+1.23 (+10.11%) increase
since 08/20/19
3-Month 7.13 +87.94% increase
on 08/15/19
Period Open:30.00
Price movement based on the high, low and last over the given period.
30.00 -55.33% decrease
on 07/02/19
-16.60 (-55.33%) decrease
since 06/20/19
52-Week 7.13 +87.94% increase
on 08/15/19
Period Open:540.00
Price movement based on the high, low and last over the given period.
590.00 -97.73% decrease
on 10/16/18
-526.60 (-97.52%) decrease
since 09/20/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).